nitroflurbiprofen has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul-Hay, SO; Ashghodom, RT; Luo, J; Thatcher, GR | 1 |
| Caniglia, S; Impagnatiello, F; L'Episcopo, F; Marchetti, B; Morale, MC; Serra, PA; Testa, N; Tirolo, C | 1 |
| Kadish, I; Miettinen, P; van Groen, T | 1 |
| De Nardi, C; Monopoli, A; Ongini, E; Thomas, GD; Victor, RG; Ye, J | 1 |
| Hauss-Wegrzyniak, B; McGann, K; Rosi, S; Wenk, GL | 1 |
| Kadish, I; van Groen, T | 1 |
| Gasparini, L; Morgan, D; Ongini, E; Wilcock, D | 1 |
| Anuar, F; Bhatia, M; Moore, PK; Whiteman, M | 1 |
| Fevery, J; Laleman, W; Nevens, F; Van der Elst, I; Van Landeghem, L; Zeegers, M | 1 |
1 review(s) available for nitroflurbiprofen and Disease Models, Animal
| Article | Year |
|---|---|
Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Flurbiprofen; Humans; Inflammation; Microglia; Structure-Activity Relationship | 2005 |
8 other study(ies) available for nitroflurbiprofen and Disease Models, Animal
| Article | Year |
|---|---|
NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Avoidance Learning; Cell Line, Tumor; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flurbiprofen; Humans; Immunoprecipitation; Lipopolysaccharides; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroblastoma; Neuroprotective Agents; Nitric Oxide Synthase Type II; Peptide Fragments; Prostaglandins; Rats; Rats, Long-Evans; Scopolamine; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetrazolium Salts; Thiazoles; Transfection | 2009 |
Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Flurbiprofen; Humans; Inflammation; Macrophage-1 Antigen; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidoreductases; Parkinson Disease; Rotarod Performance Test; Substantia Nigra; Tyrosine | 2010 |
Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Differentiation; CD11b Antigen; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Female; Flurbiprofen; Glial Fibrillary Acidic Protein; Hippocampus; Humans; Leukocyte Common Antigens; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Presenilin-1 | 2011 |
Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Disease Models, Animal; Feeding Behavior; Flurbiprofen; Hemodynamics; Hindlimb; Ischemia; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscles; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Nitric Oxide Donors; Norepinephrine; Time Factors; Vasoconstriction; Weight Gain | 2012 |
The influence of brain inflammation upon neuronal adenosine A2B receptors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Disease Models, Animal; Encephalitis; Flurbiprofen; Immunohistochemistry; Lipopolysaccharides; Male; Microglia; Neurons; Nitric Oxide Donors; Rats; Rats, Inbred F344; Receptor, Adenosine A2B; Receptors, Purinergic P1; Second Messenger Systems | 2003 |
Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
Topics: Acetylcholinesterase; Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Butyrylcholinesterase; CD11b Antigen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogens; Flurbiprofen; Fornix, Brain; Glial Fibrillary Acidic Protein; Hippocampus; Histocytochemistry; Inflammation; Male; Membrane Transport Proteins; Mice; Mice, Transgenic; Oligopeptides; Ovariectomy; Random Allocation; Vesicular Acetylcholine Transport Proteins | 2005 |
Flurbiprofen and its nitric oxide-releasing derivative protect against septic shock in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cecum; Disease Models, Animal; Flurbiprofen; Interleukin-1beta; Ligation; Male; Nitrates; Nitric Oxide; Nitrites; Rats; Rats, Sprague-Dawley; Shock, Septic; Tumor Necrosis Factor-alpha | 2006 |
Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Topics: Animals; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Flurbiprofen; Hypertension, Portal; Kidney Diseases; Liver; Liver Circulation; Liver Cirrhosis, Experimental; Male; Nitric Oxide; Nitric Oxide Donors; Peptic Ulcer; Perfusion; Portal Pressure; Rats; Rats, Wistar; Thioacetamide; Thromboxane A2; Vascular Resistance; Vasoconstriction; Vasodilation | 2007 |